This page is intended for members of the general public

Information about COVID-19 Vaccine Valneva

COVID-19 Vaccine (inactivated, adjuvanted) Valneva has been granted a marketing authorisation. It is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 to 50 years of age.

Report a possible side effect for COVID-19 Vaccine
(inactivated, adjuvanted) Valneva

If you are concerned about any potential side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet.

Either you or your healthcare professional can report any possible side effects via the national reporting system.

Please use a modern web browser